Light Mode
$1.22 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.22, $0.05 below the day’s high of $1.27
+1.06 (+664.41%) / 6M
Momentum, market sentiment, and recent alerts
VRAX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +108.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.